Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093288
Status:
COMPLETED
Last Update Posted:
2013-09-02
First Post:
2004-10-05
Brief Title:
Major Depressive Disorder In The Elderly
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Multi-Centre Randomised Double-Blind Parallel-Group Placebo-Controlled Flexible Dose Study to Evaluate the Efficacy Safety and Tolerability of Extended-release Bupropion Hydrochloride 150mg-300mg Once Daily in Elderly Subjects With Major Depressive Disorder
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a placebo-controlled study evaluating the effectiveness of medication in elderly subjects with Major Depressive Disorder MDD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None